P100 | Enhanced NAD^⁺ biosynthesis and PPP activation drive venetoclax resistance in multiple myeloma: therapeutic reversal by NAMPT inhibition (77 Online Views)

I. Traverso¹, D. Soncini^1|2, G. Giorgetti², S. Ravera³, J. Ivanisevic⁴, M. Garibotto², M. Gallo¹, F. Guolo^1|2, A. Cagnetta², R.M. Lemoli^1|2, M. Cea^1|2 | ¹Clinic of Hematology, Department of Internal Medicine and Medical Specialties DiMI, University of Genoa; ²IRCCS Ospedale Policlinico San Martino; ³Department of Experimental Medicine DIMES, University of Genoa, Italy ⁴Metabolomics Unit, Faculty of Biology and Medicine, University of Lausanne, Switzerland.